Mulmit

AMGEN INCAMGEN INC

AMGN Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2025-12-3136,751,000,0009,080,000,0007,711,000,00014.23
2024-12-3133,424,000,0007,258,000,0004,090,000,0007.56
2023-12-3128,190,000,0007,897,000,0006,717,000,00012.49
2022-12-3126,323,000,0009,566,000,0006,552,000,00012.11
2021-12-3125,979,000,0007,639,000,0005,893,000,00010.28

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-08-13Khosla RachnaSVP, Business Development1,252
2026-08-13Khosla RachnaSVP, Business Development1,252
2026-08-13Khosla RachnaSVP, Business Development1,252
2026-08-11Khosla RachnaSVP, Business Development2,000
2026-08-07Busch Matthew C.VP, Finance & CAO730
2026-08-07ISHRAK OMAR85.17
2026-08-07HOLLEY CHARLES M103.42
2026-08-07Drake Michael V63.88
2026-08-06Miller DerekSVP, Human Resources2,069
2026-08-06Miller DerekSVP, Human Resources2,069
2026-08-06Miller DerekSVP, Human Resources1,821
2026-08-06Miller DerekSVP, Human Resources1,821

8-K events

FiledItems
2026-08-04Results of operations · Financial statements and exhibits
2026-07-311.05
2026-05-20Submission of matters to a vote
2026-05-19Officer or director change
2026-04-30Results of operations · Financial statements and exhibits
2026-04-22Officer or director change · Financial statements and exhibits
2026-02-19Entry into a material agreement · Financial statements and exhibits
2026-02-03Results of operations · Financial statements and exhibits

Congressional trades (PTR)

MemberFiled
Hon. David J. Taylor2026-09-05
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

Biological Products, (No Diagnostic Substances) — 같은 업종, 그리고 규모가 비슷한 기업Biological Products, (No Diagnostic Substances) — and other companies of a similar size

SEC가 같은 업종(Biological Products, (No Diagnostic Substances))으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Biological Products, (No Diagnostic Substances)) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.